Long-term VIVID-2 data show more than 90% of patients with [...]

GSK announced that the European Commission has approved Exdensur (depemokimab) [...]

Full results from the Phase 3 KALOS and LOGOS trials [...]

M42’s Imperial College London Diabetes & Endocrine Centre and Medtronic [...]

CORXEL has completed a Series D1 financing of up to [...]

A newly published study has introduced a minimally invasive laser [...]

A rapid sepsis test used in the emergency department at [...]

India’s market for continuous glucose monitoring (CGM) devices is expected [...]

The 7th UAE Obesity Conference brought together international experts in [...]

Grifols has received US FDA approval for an expanded indication [...]